We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MEDI.OL

Price
246.00
Stock movement down
-6.00 (-2.38%)
Company name
Medistim ASA
Exchange
(OL
,
Currency
NOK
)
Sector
Healthcare >
Medical Devices
Markedsværdi
4.50B
Ent værdi
4.55B
Pris/omsætning
7.08
Pris/bog
11.71
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
34.28
Fremtidig P/E
26.91
PEG
-
EPS-vekst
7.99%
1 års afkast
49.54%
3 års afkast
-
5 års afkast
-
10 års afkast
-
Senest opdateret: 2025-12-16

UDBYTTE

MEDI.OL betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E34.28
Pris til OCF16.21
Pris til FCF19.56
Pris til EBITDA29.75
EV i forhold til EBITDA30.12

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning7.08
Pris til egenkapital11.71
EV i forhold til salg7.17

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier18.27M
EPS (TTM)-
FCF pr. aktie (TTM)-

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)-
Bruttofortjeneste (TTM)-
Driftsindkomst (TTM)-
Nettoindkomst (TTM)-
EPS (TTM)-
EPS (1 år frem)9.14

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)-
Driftsmargin (TTM)-
Fortjenstmargin (TTM)-

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter96.35M
Nettotilgodehavender94.12M
Omsætningsaktiver i alt388.07M
Goodwill14.13M
Immaterielle aktiver62.45M
Ejendomme, anlæg og udstyr0.00
Sum aktiver535.04M
Kreditor0.00
Kortfristet/nuværende langsigtet gæld0.00
Summen af kortfristede forpligtelser123.75M
Sum gæld151.23M
Aktionærernes egenkapital383.81M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)-
Investeringsudgifter (TTM)-
Fri pengestrøm (TTM)-
Udbetalt udbytte (TTM)-

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-
Afkast af aktiver-
Afkast af investeret kapital-
Kontant afkast af investeret kapital-

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning247.00
Daglig høj251.00
Daglig lav245.00
Daglig volumen25K
Højeste gennem alle tider399.00
1 års analytiker estimat315.00
Beta1.19
EPS (TTM)-
Udbytte pr. aktie0.00
Ex-div dato9 May 2025
Næste dato for resultatpræsentation27 Feb 2026

Nedsidepotensial

Loading...
Nedsidepotensial-data
MEDI.OLS&P500
Nuværende prisfald fra top notering-38.35%-1.49%
Højeste prisfald-66.92%-19.00%
Højeste efterår dato19 Nov 20248 Apr 2025
Gennemsnitlig fald fra toppen-50.37%-2.63%
Gennemsnitlig tid til nyt højdepunkt-6 days
Maks. tid til nyt højdepunkt299 days89 days
OPLYSNINGER OM VIRKSOMHEDEN
MEDI.OL (Medistim ASA) company logo
Markedsværdi
4.50B
Markedsværdi kategori
Mid-cap
Beskrivelse
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Personale
154
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Norway
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
As the European market grapples with concerns over inflated AI stock valuations and shifting interest rate expectations, the pan-European STOXX Europe 600 Index recently saw a decline of 2.21%, reflec...
24. november 2025
Medistim ASA (FRA:MD1) reports its best third quarter ever with significant growth in the Americas and Asia Pacific, despite challenges in the EMEA region.
26. oktober 2025
Medistim (OB:MEDI) posted headline numbers that reinforce its growth trajectory, with revenue forecast to climb 7.5% per year, handily outpacing the wider Norwegian market’s expected 2.3% growth rate....
25. oktober 2025
As European markets continue to rally, reaching record levels on the back of strong technology stocks and expectations for lower U.S. borrowing costs, investors are increasingly optimistic about small...
7. oktober 2025
Medistim ASA (FRA:MD1) reports a robust 16.7% revenue growth in Q2 2025, driven by significant gains in the Americas and strategic product advancements.
21. august 2025
In recent weeks, European markets have seen a positive uptick, with the pan-European STOXX Europe 600 Index rising by 1.18% amid easing trade tensions and optimism surrounding potential U.S. interest ...
20. august 2025
The European market has recently seen mixed returns across major indices, with the pan-European STOXX Europe 600 Index remaining relatively flat and individual country indices showing varied performan...
9. juli 2025
As the European market experiences a positive shift, with the pan-European STOXX Europe 600 Index rising by 0.90% and major stock indexes across Germany, Italy, France, and the UK posting gains, inves...
10. juni 2025
Medistim ASA (FRA:MD1) reports a 35.7% revenue increase, driven by strong product sales and significant market expansion in Asia Pacific.
12. maj 2025
As the pan-European STOXX Europe 600 Index continues its upward trajectory, marking a fourth consecutive week of gains amid easing trade tensions between China and the U.S., small-cap stocks have been...
12. maj 2025
Næste side